Treatment and survival of patients with pancreatic ductal adenocarcinoma: 15-year national cohort

BACKGROUND: Improvement in survival from pancreatic ductal adenocarcinoma (PDAC) has been reported in trial settings but is less explored in unselected cohorts. The aim of this study was to assess trends in provision of treatments and survival in Norway over a 15-year period following the implementa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nymo, Linn Såve, Myklebust, Tor Åge, Hamre, Hanne, Møller, Bjørn, Lassen, Kristoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902330/
https://www.ncbi.nlm.nih.gov/pubmed/35257140
http://dx.doi.org/10.1093/bjsopen/zrac004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902330/
https://www.ncbi.nlm.nih.gov/pubmed/35257140
http://dx.doi.org/10.1093/bjsopen/zrac004

Ejemplares similares